News / News highlights
Van Emden rides Aquila CV to 2nd in Dauphiné prologue
03 june 2018
The Dutchman finished the stage in Valence (Francia) with a one-second gap from Kwiatkowski
Bianchi + Team Road + Product
Jos Van Emden (Team LottoNL-Jumbo) went one-second close to victory in Critérium du Dauphiné's prologue, 6,6 km with start and finish in Valence (France) on Sunday, June 3rd. The Dutchman rode his special Bianchi Aquila CV - featuring the exclusive "celeste" CK16 coloration and hand-painted in Italy by Bianchi's expert craftsmen - to the second position clocking 7:26. Michal Kwiatkowski topped the stage (7:25), whilst Gianni Moscon (7:28) rounded out the podium. Team LottoNL-Jumbo entered the Top 20 with Lars Boom and Nelson Powless as well.
This year Van Emden had already been runner-up in Tirreno-Adriatico's final stage, a 10 km ITT in San Benedetto del Tronto (Italy) on March 13th, and also placed fourth with Aquila CV in Giro d'Italia's stage 16 in Rovereto (Italy).
Aquila CV proved a lethal weapon in the hands of LottoNL-Jumbo riders in the races against the time. It is the revolutionary time trial machine engineered with Bianchi CV system and designed to provide more energy and more control in the riding action. TT specialist, winner of 2017 Giro d’Italia’s closure in Milan's famous Piazza del Duomo, Van Emden was among the Team LottoNL-Jumbo's riders who played a key role in the testing and development of Bianchi Aquila CV.
Bianchi supplies the Team LottoNL-Jumbo with four models engineered with the Bianchi CV system:

•    Oltre XR4, designed to maximize the aerodynamic advantage and control
•    Specialissima, the ultralight frame, perfect for GC riders, it’s extra stiff for increased traction and stability at high speeds, and maximum control on the descents
•    Aquila CV, the ultimate time trial machine, designed to increase power output and rider's energy, with maximum control with ach pedal stroke
•    Infinito CV, the ideal bike for the Classics, providing remarkable control on uneven surfaces and reducing muscular fatig